Utah Medical Products (UTMD) Receives Notice of Compliance From NASDAQ
More News related to UTMD
- Utah Medical Products (UTMD) Ups Qtr. Dividend from $0.22 to $0.23/Share
- Utah Medical Products (UTMD) Reports Q3 Earnings
- Utah Medical Products (UTMD) Increases Quarterly Dividend
- Utah Medical Products (UTMD) Reports Q1 Earnings, Guides for FY-08
- Utah Medical Products (UTMD) Receives Notice of Compliance From NASDAQ
On July 25, 2006, Utah Medical Products, Inc. (Nasdaq: UTMD) received a Nasdaq Staff Deficiency Letter. The NASDAQ letter followed the resignation of Dr. Stephen W. Bennett from the board of directors on July 11, 2006.
On February 22, 2007 UTMD announced that its board of directors had elected Dr. James H. Beeson to fill the vacancy on its board of directors for the unexpired term of Dr. Stephen W. Bennett, and serve as a member of the audit committee as one of three independent directors on the board.
Today UTMD received a letter from the Nasdaq confirming, "Staff has determined that the Company [UTMD] complies with the Rule [Marketplace Rules 4350(c) and 4350(d)(2)] and this matter is now closed."
Related Categories
Corporate NewsStocks Mentioned
-0.56Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
